Pharmacology, Toxicology and Pharmaceutical Science
Tacrolimus
100%
Immunosuppressive Agent
64%
Randomized Controlled Trial
53%
Cohort Study
47%
Rapamycin
47%
Therapeutic Drug Monitoring
45%
Prevalence
39%
Pharmacodynamics
28%
Mycophenolic Acid
28%
Pharmacokinetics
28%
Gastroenterology
23%
Adverse Drug Reaction
23%
Pharmacotherapy
23%
Direct Oral Anticoagulant
23%
Liver Cirrhosis
23%
Antibiotics
23%
Mycophenolate Mofetil
23%
Chronic Kidney Failure
22%
Observational Study
11%
Long Term Survival
11%
Inflammatory Bowel Disease
9%
Autoimmune Hepatitis
9%
Combination Therapy
9%
Edoxaban
8%
Dabigatran
8%
Apixaban
8%
Adverse Event
7%
Ribavirin
5%
Health Status
5%
Viral Clearance
5%
Diabetes Mellitus
5%
Immunogenicity
5%
Hepatitis E Virus
5%
Kidney Failure
5%
Side Effect
5%
Comorbidity
5%
Medicine and Dentistry
Liver Graft
71%
Cohort Analysis
47%
Outpatient
47%
Tacrolimus
29%
Immunosuppressive Drug
29%
Medication Compliance
29%
Prevalence
29%
Immunosuppressive Treatment
23%
Hepatology
23%
Rapamycin
23%
Gastroenterology
23%
Therapeutic Drug Monitoring
23%
Quality of Life
23%
Medicine
23%
Liver Transplantation
21%
Immunosuppressant
17%
Autoimmune Hepatitis
11%
Cohort Study
11%
Adverse Drug Reaction
11%
Inflammatory Bowel Disease
11%
Visual Analog Scale
6%
Pharmacodynamics
5%
Azathioprine
5%
Mammalian Target of Rapamycin Inhibitor
5%
Mycophenolic Acid
5%
Drug Use
5%
Drug Dose Regimen
5%
Long Term Survival
5%
Observational Study
5%
Nursing and Health Professions
Liver Graft
95%
Cohort Analysis
47%
Tacrolimus
47%
Outpatient
47%
Rapamycin
47%
Clinical Pharmacist
47%
Low Drug Dose
27%
Quality of Life
23%
Immunosuppressive Treatment
23%
Medication Compliance
21%
Prevalence
21%
Compliance
11%
Adverse Drug Reaction
11%
Chronic Kidney Failure
10%
Estimated Glomerular Filtration Rate
10%
Liver Transplantation
9%
Visual Analog Scale
6%
Combination Therapy
6%
Drug Dose Regimen
5%
Drug Use
5%
Long Term Survival
5%
Outpatient Department
5%
Immunosuppressive Agent
5%
Medication Therapy Management
5%
